The Seer spinoff recently closed a $46 million funding round that it is using to support efforts in nucleic acid, proteomic, and metabolomic biomarker discovery.
Read the full article in GenomeWeb here.
July 13, 2023
Apparently Getting Smarter Makes Us Healthier: AI And Data Analysis Revolutionize Healthcare
June 21, 2022
PrognomiQ partners with KSM to discover cancer biomarkers
March 15, 2022
PrognomiQ lands $46M from Bruker for multiomics platform
